WHWK
Whitehawk (WHWK)
NASDAQ
$4.34$0.00 (0.00%)
Price as of Jun 03, 2026 4:10 PM EDT
  • $233.4M
    Market Cap
  • 145.88%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 64
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$4.14
$4.35
$4.34
1-Year Range
$1.60
$5.10
$4.34
Latest Close$4.34
Change
+$0.16 (+3.69%)
Volume168,245
Market Cap$233.4M
Shares Outstanding49.5M
P/E (TTM)-2.82
Diluted EPS (TTM)-$1.68
Enterprise Value$198.6M

Information as of 06/03/2026

Company Profile

WHITEHAWK THERAPEUTICS INC
WHITEHAWK THERAPEUTICS INC
https://ir.whitehawktx.com
$233.4M
Market Cap
-$115.8M
Net Income
Sector: Healthcare
Industry: Biotechnology
2 Headquarters Plaza, Morristown, NJ, United States, 07960
551-321-2234

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Key Executives

  • David J. Lennon
  • Scott Giacobello
  • Bryan Ball
  • Neil Desai
  • Margaret Han Dugan

Current Ownership Distribution

  • Other24.9M (50.28%)
  • Insiders16.9M (34.21%)
  • Mutual Funds7.7M (15.51%)
  • Institutions0 (0.00%)